Answers are grounded in this paper and cite their sources.
Investigates RBC aggregation and biomarkers related to angiogenesis and hypoxia in PDAC patients, suggesting potential links.
Background/Objectives: This study aimed to investigate the effect of pancreatic ductal adenocarcinoma (PDAC) on the alterations in red blood cell aggregation related to angiogenesis and hypoxia markers. Methods: We studied 31 patients with confirmed PDAC. The aggregation of red blood cells (RBCs) was evaluated using a Laser-assisted Optical Rotational Cell Analyzer (LORCA). Serum vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α) levels were measured using ELISA. We estimated the following parameters specific to the aggregation process: the aggregation index (AI), the aggregation half-time (t1/2), and the threshold shear rate (γthr). Results: All measured RBC aggregation parameters among PDAC subjects differed from those in the controls. The AI (p < 0.05) and γthr (p < 0.005) were significantly higher in the PDAC group, whereas t1/2 (p < 0.01) and AMP (p < 0.001) were significantly lower compared to the control group. The levels of VEGF (p < 0.0001) and HIF-1α (p < 0.0001) were significantly higher in the PDAC group than in the control group. There were significant correlations between RBC aggregation parameters and VEGF and HIF-1α. Multivariate analyses further identified t1/2 (p < 0.01) and γthr (p < 0.05) as independent predictors for VEGF. For HIF-1α, t1/2 (p < 0.05) was confirmed as an independent predictor. Conclusions: The results suggest, but do not demonstrate, a direct pathophysiological link between PDAC-associated hypoxia/angiogenesis and erythrocyte aggregation. Further studies are needed because the relationship linking PDAC to these aggregation indices is unclear.
No takes yet. Share an insight, caveat, or question.
Wiewióra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: